Quantitative comparison of glucagon-like peptide-1 receptor agonists on weight loss in adults: a systematic review and model-based meta-analysis
Zhang S, Yu B, Xu J, et al.
Diabetes Technol Ther. Pub. online 6 Feb 2025.
Leggi
Patient and physician factors driving the gaps in use of drugs with cardiovascular and kidney benefits by medicare beneficiaries with type 2 diabetes treated by endocrinologists, nephrologists, and cardiologists: population-based cohort study
McCoy RG, Vandergrift JL, Gray B
Diabetes Res Clin Pract. 2025:112039.
Leggi
Time in targeted blood glucose range as an independent predictor of 28-day mortality in ICU patients: a retrospective study
Zhao J, Huang D, Hua S, et al.
Diabetes Res Clin Pract. 2025:112033.
Leggi
Real-world evidence supporting the use of advanced hybrid closed loop in poorly controlled type 1 diabetes patients
Graf S, Hofer G, Hirschmann R, et al.
Diabetes Res Clin Pract. 2025:112035.
Leggi
Long-term outcomes of pancreatic islet transplantation alone in type 1 diabetes: a 20-year single-centre study in Italy
Catarinella D, Melzi R, Mercalli A, et al.
Lancet Diabetes Endocrinol. Pub. online 6 Feb 2025.
Leggi
Efficacy and hypoglycaemia outcomes with once-weekly insulin icodec versus once-daily basal insulin in individuals with type 2 diabetes by kidney function: a post hoc participant-level analysis of the ONWARDS 1-5 trials
Rossing P, Benamar M, Cheng AYY, et al.
Diabetes Obes Metab. Pub. online 10 Feb 2025.
Leggi
Lung function impairment and risks of incident cardiovascular diseases and mortality among people with type 2 diabetes: a prospective cohort study
Chen C, Huang Z, Liu L, et al.
Diabetes Care. 2025:dc242188.
Leggi
Repeated OGTT versus continuous glucose monitoring for predicting development of stage 3 type 1 diabetes: a longitudinal analysis
Desouter AK, Keymeulen B, Van de Velde U, et al.
Diabetes Care. 2025 Feb 4:dc242376.
Leggi